Delivery Order SPE2DE24D0013-SPE2D625F6EP5

The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on July 10, 2025, with an ultimate completion date of July 17, 2025. The contract, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems, will perform the work at its headquarters location. This delivery order carries no set-aside designation and represents a short-duration procurement typical of immediate diagnostic supply needs within the defense healthcare enterprise.

This award likely operates under or complements Cepheid's existing federal indefinite delivery vehicle contracts, including the company's significant $32.8 million Veterans Integrated Service Network 6 IDV with the Department of Veterans Affairs covering molecular diagnostic testing systems and reagents through September 2030. Cepheid has demonstrated substantial experience providing GeneXpert diagnostic systems, molecular reagents, and test kits across multiple federal healthcare agencies, including the VA, Defense Logistics Agency, and Defense Health Agency. The company's established presence in federal molecular diagnostics procurement, combined with its specialized expertise in infectious disease detection platforms, positions it as a key supplier for the DOD's diagnostic testing requirements.